The law offices of frank r. How to buy shares in athira pharma.
Athira Pharma Inc Common Stock Atha Stock Price Quote News History Nasdaq
As of november 15th, there was short interest totaling.

Athira pharma stock buy. Compare share trading platforms.use our comparison table to help you find a platform that fits you. Atha athira pharma inc — stock price and discussion | stocktwits. Complete an application with your details.
Among the rest, 0 recommended atha as a hold, whereas 4 deemed it a buy, and 0 rated it as underweight. The upgrade of athira pharma, inc. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a sell;
Cruz announced that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired athira pharma, inc. Should i buy athira pharma (atha)? Nasdaq stock exchange > watchlist.
(atha) stock quote, history, news and other vital information to help you with your stock trading and investing. Another 0 rate it as overweight. (atha) has been upgraded to a zacks rank #2 (buy), reflecting growing optimism about the company's earnings prospects.
13, 2020 at 7:11 a.m. Et by tomi kilgore athira pharma's stock pulls back after the open, trades briefly below ipo. Other robinhood financial fees may apply, check rbnhd.co/fees for details.
Get a free stock at robinhood. Atha) is owned by 66.65% institutional shareholders, 25.90% athira pharma insiders, and 7.45% retail investors. Among the rest, no body recommended atha as a hold, whereas 4 deemed it a buy, and no one rated.
If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a sell; Athira pharma stocks (atha.us) are listed on the nasdaq and all prices are listed in us dollars. Athira pharma started at buy with $36 stock price target at stifel nicolaus oct.
Are investors shorting athira pharma? Of the 90 institutional investors that purchased athira pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Advisors llc perceptive is the largest individual athira pharma shareholder, owning 3.43m shares representing 9.17% of the company.
Find the latest athira pharma, inc. The consensus among wall street equities research analysts is that investors should buy athira pharma stock. Volume has increased on the last day by.
Use the zacks rank and style scores to find out is atha is right for your portfolio. ($1.67m), vr adviser llc ($1.52m), logos global management lp ($1.48m), wasatch advisors inc. The law offices of frank r.
Athira pharma employs 20 staff and has a market cap (total outstanding stock value) of $586.7 million. Today atha ranks #1970 as buy candidate. Common stock pursuant and/or traceable to the registration.
On average, wall street analysts predict that. Stock received a consensus recommendation rating of a buy, based on a mean score of 1.50. Another but none rate it as overweight.
Athira pharma inc nasdaq updated sep 16, 2021 8:03 am. Advisors llc perceptive's athira pharma shares are currently valued at $50.43m. Seattle, september 17, 2020 — athira pharma, inc., (nasdaq:
Athira pharma 10%+ owner joseph edelman reported purchase of 311,111 shares @ avg price of $22.50/share in form 4 filing on wednesday. Perceptive advisors llc ($3.43m), blackrock inc. Athira pharma saw a increase in short interest during the month of november.
The average athira pharma stock price prediction forecasts a potential downside of n/a from the current atha share price of $14.60. Stock signals nasdaq:atha latest data & signals issued. Athira pharma announces proposed public offering of common stock.
Athira pharma's share price could stay at $34.00 by nov 11, 2022. Stock received a consensus recommendation rating of buy, based on a mean score of 1.5. (atha) stock sinks as market gains:
Bothell, washington, january 20, 2021 — athira pharma, inc. Cruz announces the filing of securities class action on behalf of athira pharma, inc. Athira pharma is a biotechnology business based in the us.
Signal type signal value data;
Atha Stock Price And Chart Nasdaqatha Tradingview
Atha Stock Forecast Price News Athira Pharma
Atha Alert - Nationally Ranked Shareholder Rights Firm Labaton Sucharow Is Investigating Athira Pharma Inc Nasdaqatha For Potential Securities Violations And Breach Of Fiduciary Duty
Htyiwwol5bbqcm
Athira Pharma Inc Share Price Usd00001
Athira Pharma Announces Pricing Of Public Offering Of Common Stock - Athira Pharma
Athira Chief Executive Resigns As Company Confirms She Altered Research
Goldman Sachs 2 Stocks That Could Climb Over 90 Nasdaq
Athira Pharma Inc Atha Stock Price Us04746l1044 Marketscreener
Atha Stock Price Today Plus 7 Insightful Charts Dogs Of The Dow
Atha Stock Price And Chart Nasdaqatha Tradingview
Why Shares Of Athira Pharma Are Climbing Today The Motley Fool
Atha Stock Price And Chart Nasdaqatha Tradingview
Atha - Athira Pharma Stock Plummets After Ceo Placed On Temporary Leave U_teamofstocktraders
Athira Pharma Announces Pricing Of Public Offering Of Common Stock - Athira Pharma
Why Athira Pharma Stock Dropped Today The Motley Fool
Athira Pharma Stock Climbs On Alzheimers Test As Ceo Resigns - Thestreet
Atha Stock Price And Chart Nasdaqatha Tradingview
Atha Stock Price And Chart Nasdaqatha Tradingview
Comments
Post a Comment